Spero Therapeutics, Inc.
						SPRO
					
					
							
								$2.42
								$0.041.88%
								
							
						NASDAQ
					
				| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.90% | -40.58% | -30.71% | -18.69% | -18.23% | 
| Total Receivables | -51.50% | -55.22% | 3.51% | 1,682.60% | 2,557.81% | 
| Inventory | -- | -- | -- | -- | -- | 
| Prepaid Expenses | -59.48% | -57.80% | -54.26% | -62.00% | -62.71% | 
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- | 
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- | 
| Other Current Assets | -- | -- | -- | -- | -- | 
| Total Current Assets | -51.40% | -46.69% | -18.24% | 28.77% | 38.34% | 
| 
										 | 
								|||||
| Total Current Assets | -51.40% | -46.69% | -18.24% | 28.77% | 38.34% | 
| Net Property, Plant & Equipment | -29.64% | -27.20% | -25.09% | -23.94% | -24.02% | 
| Long-term Investments | -- | -- | -- | -- | -- | 
| Goodwill | -- | -- | -- | -- | -- | 
| Total Other Intangibles | -- | -- | -- | -- | -- | 
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- | 
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- | 
| Total Other Assets | -99.36% | -99.35% | -99.67% | -64.75% | 318.45% | 
| Total Assets | -58.55% | -53.66% | -39.39% | 26.20% | 51.57% | 
| 
										 | 
								|||||
| Total Accounts Payable | -71.07% | -42.43% | 430.19% | 452.13% | 105.80% | 
| Total Accrued Expenses | -33.63% | 49.55% | 433.66% | 133.55% | 79.99% | 
| Short-term Debt | -- | -- | -- | -- | -- | 
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- | 
| Finance Division Debt Current | 6.47% | 4.06% | 1.63% | 1.64% | 1.64% | 
| Total Finance Division Other Current Liabilities | -81.80% | -44.55% | 63.83% | 61.27% | 256.58% | 
| Total Other Current Liabilities | -81.80% | -44.55% | 63.83% | 61.27% | 256.58% | 
| Total Current Liabilities | -67.25% | -30.29% | 32.09% | 92.83% | 163.41% | 
| 
										 | 
								|||||
| Total Current Liabilities | -67.25% | -30.29% | 32.09% | 92.83% | 163.41% | 
| Long-Term Debt | -- | -- | -- | -- | -- | 
| Short-term Debt | -- | -- | -- | -- | -- | 
| Capital Leases | -44.76% | -38.48% | -33.31% | -30.02% | -27.25% | 
| Finance Division Debt Non Current | -- | -- | -- | -- | -- | 
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- | 
| Total Other Liabilities | -38.78% | -51.85% | -62.93% | -25.78% | -8.18% | 
| Total Liabilities | -57.78% | -38.57% | -14.67% | 30.45% | 57.32% | 
| 
										 | 
								|||||
| Common Stock & APIC | 1.18% | 1.47% | 1.57% | 1.67% | 1.67% | 
| Retained Earnings | -12.71% | -17.28% | -17.53% | 0.79% | 3.98% | 
| Treasury Stock & Other | -- | -- | -- | -- | -- | 
| Total Common Equity | -59.22% | -64.87% | -56.85% | 21.98% | 46.95% | 
| 
										 | 
								|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- | 
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- | 
| Preferred Stock Convertible | -- | -- | -- | -- | -- | 
| Preferred Stock, Others | -- | -- | -- | -- | -- | 
| Total Preferred Equity | -- | -- | -- | -- | -- | 
| 
										 | 
								|||||
| Total Common Equity | -59.22% | -64.87% | -56.85% | 21.98% | 46.95% | 
| Total Preferred Equity | -- | -- | -- | -- | -- | 
| Total Minority Interest | -- | -- | -- | -- | -- | 
| Total Equity | -59.22% | -64.87% | -56.85% | 21.98% | 46.95% | 
| 
										 | 
								|||||